Advertisement
IDEAYA Biosciences Q4 Results Misses Estimates
(RTTNews) - IDEAYA Biosciences, Inc. (IDYA), a precision medicine oncology company, announced net loss of $32.64 million or $0.52 per share, wider than $23.07 million or $0.50 per share in the prior-year quarter.
Collaboration revenues for the quarter declined to $3.92 million from $4.02 million in the same quarter last year.
On average, ten analysts polled by Thomson Reuters expected the company to report a loss of $0.47 per share on revenues of $8.84 million for the quarter. Analysts' estimates typically exclude special items.
For more earnings news, earnings calendar, and earnings for stocks, visit rttnews.com
read more
IDEAYA Biosciences Says FDA Clears IND For Pol Theta Helicase Development Candidate GSK101
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced Monday the clearance of an Investigational New Drug (IND) application with the U.S. Food and Drug Administration (FDA) for initiation of a GSK-sponsored Phase 1/2 clinical trial to evaluate GSK101 (IDE705) for the treatment of patients having tumors with BRCA or other homologous recombination (HR) mutations or homologous recombination deficiency (HRD).
RTTNews
|
814 ngày trước
IDEAYA Biosciences Appoints Darrin Beaupre As Chief Medical Officer
Oncology company IDEAYA Biosciences, Inc. (IDYA) announced that Darrin Beaupre has joined the company as its Chief Medical Officer, effective November 21, 2022.
RTTNews
|
1080 ngày trước
Bay Street May Open On Positive Note Again
Canadian stocks may open higher on Wednesday amid optimism about an end to the U.S. government shutdown. Firm European stocks and expectations of an interest rate cut by the Federal Reserve next month may also help underpin sentiment.
RTTNews
|
1h 15phút trước
FTSE 100 Pares Early Gains; SSE Soars 12%
After opening marginally higher and moving up a bit subsequently, the U.K. market's FTSE 100 slipped into negative territory on Wednesday, with investors looking for direction and largely refraining from making significant moves.
RTTNews
|
2h 32phút trước
CAC 40 Extends Gains To 3rd Straight Day, Rises Over 1%
French stocks are up in positive territory on Wednesday, extending gains to a third straight session, led by gains in financial and luxury sectors.
Expectations of an interest rate cut by the Federal Reserve next month, and hopes that the government shutdown in the U.S. will likely end this week help underpin sentiment.
RTTNews
|
3h 30phút trước
DAX Climbs To 4-week High On Inflation Data, Earnings
Germany's DAX climbed to a four-week high on Wednesday with investors continuing to pick up stocks amid hopes the US government shutdown will come to an end soon, and expectations of an interest rate cut by the Federal Reserve in December.
RTTNews
|
3h 56phút trước
Sensex, Nifty Surge On Trade Deal Hopes; IT Stocks Lead Gains
Indian shares rose notably on Wednesday, with U.S. shutdown resolution and growing optimism over a potential trade deal with the United States boosting sentiment.
RTTNews
|
4h 54phút trước
Yen Falls After Japan PM Takaichi Comments
The Japanese yen weakened against other major currencies in the Asian session on Wednesday, as Japan's Prime Minister Sanae Takaichi signals a looser fiscal target and calls for caution in the Bank of Japan (BoJ) rate hike.
RTTNews
|
5h 55phút trước
